vs
HARROW, INC.（HROW）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
STURM RUGER & CO INC的季度营收约是HARROW, INC.的1.7倍（$151.1M vs $89.1M），HARROW, INC.同比增速更快（33.3% vs 3.6%），STURM RUGER & CO INC自由现金流更多（$12.3M vs $8.1M），过去两年HARROW, INC.的营收复合增速更高（60.5% vs 5.1%）
哈罗健康（前身为Imprimis制药）是一家上市制药企业，总部位于美国田纳西州纳什维尔，深耕制药领域相关业务，在医药研发、生产及商业化方面拥有成熟的运营体系，产品及服务覆盖多个医疗需求场景。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
HROW vs RGR — 直观对比
营收规模更大
RGR
是对方的1.7倍
$89.1M
营收增速更快
HROW
高出29.7%
3.6%
自由现金流更多
RGR
多$4.3M
$8.1M
两年增速更快
HROW
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $89.1M | $151.1M |
| 净利润 | $6.6M | — |
| 毛利率 | 79.3% | 17.8% |
| 营业利润率 | 17.5% | 2.3% |
| 净利率 | 7.4% | — |
| 营收同比 | 33.3% | 3.6% |
| 净利润同比 | -2.2% | — |
| 每股收益（稀释后） | $0.20 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HROWRGR
| Q4 25 | $89.1M | $151.1M | ||
| Q3 25 | $71.6M | $126.8M | ||
| Q2 25 | $63.7M | $132.5M | ||
| Q1 25 | $47.8M | $135.7M | ||
| Q4 24 | $66.8M | $145.8M | ||
| Q3 24 | $49.3M | $122.3M | ||
| Q2 24 | $48.9M | $130.8M | ||
| Q1 24 | $34.6M | $136.8M |
净利润HROWRGR
| Q4 25 | $6.6M | — | ||
| Q3 25 | $1.0M | $1.6M | ||
| Q2 25 | $5.0M | $-17.2M | ||
| Q1 25 | $-17.8M | $7.8M | ||
| Q4 24 | $6.8M | — | ||
| Q3 24 | $-4.2M | $4.7M | ||
| Q2 24 | $-6.5M | $8.3M | ||
| Q1 24 | $-13.6M | $7.1M |
毛利率HROWRGR
| Q4 25 | 79.3% | 17.8% | ||
| Q3 25 | 75.3% | 15.1% | ||
| Q2 25 | 74.5% | 3.9% | ||
| Q1 25 | 67.5% | 22.0% | ||
| Q4 24 | 78.8% | 22.8% | ||
| Q3 24 | 75.6% | 18.5% | ||
| Q2 24 | 74.4% | 22.3% | ||
| Q1 24 | 69.5% | 21.5% |
营业利润率HROWRGR
| Q4 25 | 17.5% | 2.3% | ||
| Q3 25 | 20.6% | -2.7% | ||
| Q2 25 | 17.9% | -15.6% | ||
| Q1 25 | -23.5% | 6.2% | ||
| Q4 24 | 19.3% | 7.8% | ||
| Q3 24 | 2.7% | 3.1% | ||
| Q2 24 | 3.1% | 6.9% | ||
| Q1 24 | -20.0% | 5.5% |
净利率HROWRGR
| Q4 25 | 7.4% | — | ||
| Q3 25 | 1.4% | 1.2% | ||
| Q2 25 | 7.8% | -13.0% | ||
| Q1 25 | -37.2% | 5.7% | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | -8.6% | 3.9% | ||
| Q2 24 | -13.2% | 6.3% | ||
| Q1 24 | -39.2% | 5.2% |
每股收益（稀释后）HROWRGR
| Q4 25 | $0.20 | $0.22 | ||
| Q3 25 | $0.03 | $0.10 | ||
| Q2 25 | $0.13 | $-1.05 | ||
| Q1 25 | $-0.50 | $0.46 | ||
| Q4 24 | $0.19 | $0.62 | ||
| Q3 24 | $-0.12 | $0.28 | ||
| Q2 24 | $-0.18 | $0.47 | ||
| Q1 24 | $-0.38 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $92.5M |
| 总债务越低越好 | $250.0M | — |
| 股东权益账面价值 | $52.4M | $283.8M |
| 总资产 | $399.5M | $342.0M |
| 负债/权益比越低杠杆越低 | 4.77× | — |
8季度趋势，按日历期对齐
现金及短期投资HROWRGR
| Q4 25 | $72.9M | $92.5M | ||
| Q3 25 | $74.3M | $80.8M | ||
| Q2 25 | $53.0M | $101.4M | ||
| Q1 25 | $66.7M | $108.3M | ||
| Q4 24 | $47.2M | $105.5M | ||
| Q3 24 | $72.6M | $96.0M | ||
| Q2 24 | $71.0M | $105.6M | ||
| Q1 24 | $76.0M | $115.3M |
总债务HROWRGR
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
股东权益HROWRGR
| Q4 25 | $52.4M | $283.8M | ||
| Q3 25 | $47.0M | $279.6M | ||
| Q2 25 | $49.7M | $289.3M | ||
| Q1 25 | $56.5M | $321.5M | ||
| Q4 24 | $69.7M | $319.6M | ||
| Q3 24 | $58.0M | $314.9M | ||
| Q2 24 | $58.5M | $321.5M | ||
| Q1 24 | $60.6M | $332.0M |
总资产HROWRGR
| Q4 25 | $399.5M | $342.0M | ||
| Q3 25 | $363.1M | $342.3M | ||
| Q2 25 | $345.0M | $349.5M | ||
| Q1 25 | $364.2M | $379.0M | ||
| Q4 24 | $389.0M | $384.0M | ||
| Q3 24 | $351.5M | $373.5M | ||
| Q2 24 | $306.6M | $376.7M | ||
| Q1 24 | $295.5M | $385.0M |
负债/权益比HROWRGR
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.4M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | $12.3M |
| 自由现金流率自由现金流/营收 | 9.1% | 8.2% |
| 资本支出强度资本支出/营收 | 0.4% | 2.1% |
| 现金转化率经营现金流/净利润 | 1.27× | — |
| 过去12个月自由现金流最近4个季度 | $43.0M | $38.5M |
8季度趋势，按日历期对齐
经营现金流HROWRGR
| Q4 25 | $8.4M | $15.5M | ||
| Q3 25 | $16.6M | $12.9M | ||
| Q2 25 | $-803.0K | $14.7M | ||
| Q1 25 | $19.7M | $11.1M | ||
| Q4 24 | $-17.8M | $20.0M | ||
| Q3 24 | $3.0M | $9.4M | ||
| Q2 24 | $-2.7M | $18.7M | ||
| Q1 24 | $-4.6M | $7.3M |
自由现金流HROWRGR
| Q4 25 | $8.1M | $12.3M | ||
| Q3 25 | $16.4M | $7.0M | ||
| Q2 25 | $-969.0K | $9.1M | ||
| Q1 25 | $19.5M | $10.0M | ||
| Q4 24 | $-18.3M | $16.4M | ||
| Q3 24 | $2.3M | $2.6M | ||
| Q2 24 | $-3.1M | $10.1M | ||
| Q1 24 | $-4.7M | $5.6M |
自由现金流率HROWRGR
| Q4 25 | 9.1% | 8.2% | ||
| Q3 25 | 22.9% | 5.5% | ||
| Q2 25 | -1.5% | 6.9% | ||
| Q1 25 | 40.8% | 7.4% | ||
| Q4 24 | -27.4% | 11.2% | ||
| Q3 24 | 4.8% | 2.1% | ||
| Q2 24 | -6.3% | 7.7% | ||
| Q1 24 | -13.6% | 4.1% |
资本支出强度HROWRGR
| Q4 25 | 0.4% | 2.1% | ||
| Q3 25 | 0.3% | 4.6% | ||
| Q2 25 | 0.3% | 4.2% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 0.8% | 2.5% | ||
| Q3 24 | 1.2% | 5.5% | ||
| Q2 24 | 0.7% | 6.6% | ||
| Q1 24 | 0.3% | 1.3% |
现金转化率HROWRGR
| Q4 25 | 1.27× | — | ||
| Q3 25 | 16.26× | 8.15× | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | -2.62× | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HROW
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
